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OBJECTIVE—Pathology associated with oxidative stress fre-
quently results in insulin resistance. Glutathione (GSH) and
GSH-linked metabolism is a primary defense against oxidative
stress. Electrophilic lipid alkenals, such as 4-hydroxy-t-2-nonenal
(4HNE), generated during oxidative stress are metabolized pri-
marily to glutathione electrophile (GS-E) conjugates. Recent
studies show that RLIP76 is the primary GS-E conjugate trans-
porter in cells, and a regulator of oxidative-stress response.
Because RLIP76
/ mice are hypoglycemic, we studied the role
of RLIP76 in insulin resistance.
RESEARCH DESIGN AND METHODS—Blood glucose, insu-
lin, lipid measurements, and hyperinsulinemic-euglycemic and
hyperglycemic clamp experiments were performed in RLIP76
/
and RLIP76
/ C57B mice, using Institutional Animal Care
and Use Committee–approved protocols. Time-resolved three-
dimensional confocal ﬂuorescence microscopy was used to
study insulin endocytosis.
RESULTS—The plasma insulin/glucose ratio was ordered
RLIP76
/  RLIP76
/  RLIP76
/; administration of puriﬁed
RLIP76 in proteoliposomes to RLIP76
/ animals further in-
creased this ratio. RLIP76 was induced by oxidative or hypergly-
cemic stress; the concomitant increase in insulin endocytosis
was completely abrogated by inhibiting the transport activity of
RLIP76. Hydrocortisone could transiently correct hypoglycemia
in RLIP76
/ animals, despite inhibited activity of key glucocor-
ticoid-regulated hepatic gluconeogenic enzymes, phosphoenol-
pyruvate carboxykinase, glucose-6-phosphatase, and fructose
1,6-bisphosphatase, in RLIP76
/.
CONCLUSIONS—The GS-E conjugate transport activity of
RLIP76 mediates insulin resistance by enhancing the rate of
clathrin-dependent endocytosis of insulin. Because RLIP76 is
induced by oxidative stress, it could play a role in insulin
resistance seen in pathological conditions characterized by in-
creased oxidative stress. Diabetes 59:714–725, 2010
O
xidative stress is implicated in chronic diseases
(1–4) including insulin resistance that leads to
type 2 diabetes (5–8). Pancreatic -cells are
relatively susceptible to the damaging effects of
free radicals because of low levels of free radical quench-
ing enzymes including catalase, glutathione peroxidase,
and superoxide dismutase (9). Short exposure of -cells to
H2O2 suppresses insulin mRNA levels and insulin secre-
tion (10). Likewise, exposure of -cells to high glucose
concentrations leads to increased intracellular free radical
content and inhibited insulin release (11). Reactive oxygen
species (ROS) generated during oxidative stress are
known to activate signaling proteins including stress ki-
nases (e.g., c-Jun NH2-terminal kinase, p38, inhibitor of B
kinase) in addition to the extracellular receptor kinases
that can affect the cellular response to insulin. The down-
regulation of insulin response under oxidant exposure
involves activation of tumor necrosis factor-; increased
Ser/Thr phosphorylation of insulin receptor and insulin
receptor substrate-1 (IRS1) (12,13) reduces the redistribu-
tion of IRS1 and phosphatidylinositol 3 kinase from the
cytosolic to microsomal fraction, reduces protein kinase-B
(Akt) phosphorylation, and results in decreased trafﬁcking
of GLUT4 to the plasma membrane. Prolonged exposure
to oxidative stress also affects the transcription of GLUT4
(14).
In parallel with the protein signaling pathway described
above, a chemical signaling pathway is activated by oxi-
dative stress. This pathway begins with ROSs derived from
oxidative degradation of polyunsaturated fatty acids, and
is linked with multiple protein signaling pathways. Activa-
tion of protein kinase C and nuclear factor-B results in
increased activity of NADPH oxidase (15), which ampliﬁes
oxidative stress by augmenting the recycling of Fe
3 to
Fe
2 (16). The autocatalytic chain reaction of lipid peroxi-
dation, where a single lipid peroxide species can lead to
the formation of up to a thousand lipid peroxides, provides
a built-in magniﬁcation for ROS-mediated signaling. The -
and -unsaturated lipid aldehydes generated through
-scission of linoleic acid, -linoleic acid, or arachidonic
acid hydroperoxides play an important role in this signal-
ing. 4-Hydroxy-t-2-nonenal (4HNE), the most abundant
alkenal generated in cells, is a versatile second messenger
for signaling that can affect multiple signaling pathways
including those for apoptosis, differentiation, proliferation,
and receptor tyrosine-kinase (RTK)–mediated signaling
(17,18).
4HNE controls the expression and activity of many
signaling proteins involved in insulin resistance, including
stress kinases, nuclear factor-B, and chaperones (19),
and affects RTK signaling, thus HNE could modulate
insulin signaling and glucose homeostasis. Glutathione
transferases (particularly GSTA4–4) and RLIP76 (a 76-kDa
splice variant, encoded by the human gene RALBP1) are
the two major determinants of 4HNE levels in cells (20).
Although 4HNE is substrate for several enzymes including
aldehyde dehydrogenases, aldose reductase, and Cyt-p450,
the major pathway for its disposition from cells is through
its GST catalyzed conjugation to GSH (20) and subsequent
ATP-dependent transport of the conjugate (GS-HNE) cat-
alyzed by RLIP76 (21). The mechanisms for the efﬂux of
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involving other ABC transporters, but knockout mouse
studies have shown that RLIP76 plays a dominant role
(22,23). The relevance of RLIP76 to insulin resistance is
also suggested by its known function as a component of
clathrin-dependent endocytosis (22–26), a determinant of
the duration of ligand-receptor signal. Present studies
provide evidence for a novel model in which the mecha-
nisms of insulin resistance are directly linked to mercap-
turic acid pathway through the role of RLIP76 as an
energy-providing component of clathrin-dependent endo-
cytosis. Compelling evidence for this model is presented in
this communication.
RESEARCH DESIGN AND METHODS
Quantiﬁcation of insulin, glucose, and lipid levels in wild-type and
RLIP76 knockout mice. Animal experiments were carried out in accordance
with an Institutional Animal Care and Use Committee (IACUC)–approved
protocol. Twelve-week-old C57BL/6 mice born of heterozygous  heterozy-
gous (RLIP76
/  RLIP76
/) mating were genotyped by PCR strategy on
mouse tail DNA using forward, reverse, and long terminal region primers (27).
Insulin and glucose measurement in blood serum was performed on wild-type
(RLIP76
/) animals killed 24 h after a single intraperitoneal injection of
control or RLIP76 liposomes equivalent to 200 and 500 	g RLIP76 protein.
Insulin and glucose measurement in blood serum was also performed on
heterozygous (RLIP76
/) and homozygous (RLIP76
/) animals. Cholesterol,
triglycerides, glucose, and insulin measurements were reassayed and veriﬁed
in the laboratory of Dr. Kent R. Refsal, Michigan State University, East
Lansing, Michigan. Uptake of RLIP76 by tissues of RLIP76 proteoliposome–
injected mice was monitored by comparing the results of Western blots of
tissues of wild-type mice with or without administration of RLIP76
proteoliposomes.
Hyperinsulinemic-euglycemic and hyperglycemic clamp experiments.
Hyperinsulinemic-euglycemic and hyperglycemic clamp experiments were
performed by the Mouse Metabolic Phenotyping Center at the Yale University
School of Medicine, with procedures approved by Yale University Institutional
Animal Care and Use Committee. Brieﬂy, RLIP76
/ and RLIP76
/ mice were
anesthetized with an intraperitoneal injection of ketamine and xylazine, a
catheter was inserted in the right jugular vein, a 3-way connector was attached
to the jugular vein catheter for intravenous infusion, and blood samples were
obtained from tail vessels, requiring a small tail cut. A 2-h hyperinsulinemic-
euglycemic clamp was conducted with a primed-continuous infusion of
human insulin at a rate of 15 pmol  kg
1  min
1 to raise plasma insulin within
a physiological range (
300 pmol/l). Blood samples were collected at 10- to
20-min intervals for the immediate measurement of plasma glucose concen-
tration, and 20% glucose was infused at variable rates to maintain glucose at
basal concentrations (
6 mmol/l). Insulin-stimulated whole-body glucose
metabolism was assessed with a continuous infusion of 3-[
3H] glucose (0.1
mCi/min) throughout the clamps. Basal rates of whole-body glucose turnover
were assessed using a primed-continuous infusion of 3-[
3H] glucose for 2 h
prior to the start of clamp. To estimate insulin-stimulated glucose uptake in
individual tissues, 2-deoxy-D-1-[
14C] glucose (2-[
14C] DG) is administered as a
bolus (10 mCi) at 75 min after the start of clamp. Blood samples were taken
at 0–120 min of clamp for the measurement of plasma 3-[
3H] glucose and/or
2-[
14C] DG concentrations. Additional blood samples were collected before
and at the end of clamp for the measurement of plasma insulin concen-
trations. A 2-h hyperglycemic clamp is conducted with a variable infusion
of 20% glucose to raise and maintain plasma glucose concentrations at 
16
mmol/l. Blood samples were collected at 10- to 20-min intervals for the
immediate measurement of plasma glucose concentrations using Beckman
Glucose Analyzer. The area under curve of plasma glucose and insulin
proﬁles was assessed to determine glucose-induced insulin secretion in
vivo (28).
Phosphoenolpyruvate carboxykinase, fructose 1,6-bisphosphatase, and
glucose-6-phosphatase activity in wild-type and RLIP76 knockout mice.
The method of Opie and Newsholme (29) was used for phosphoenolpyruvate
carboxykinase (PEPCK) assay. Fructose 1,6-bisphosphatase (F-1,6-BPase)
was assayed by the method of Taketa and Pogell (30). Glucose-6-phosphatase
(G6Pase) activity was determined using the method of Gierow and Jergil (31).
Expression of PEPCK, F-1,6-BPase, and G6Pase genes in wild-type
(RLIP76
/) and RLIP76 knockout (RLIP76
/) mouse liver tissues was also
quantitated by RT-PCR analysis using QIAGEN one-step RT-PCR kit following
manufacturer’s instructions. Brieﬂy, liver tissues were placed in RNAlater
reagent and RNA was isolated using RNeasy tissue kit (QIAGEN) and was
quantiﬁed; purity was determined by measuring absorbance at 260 and 280
nm. All primers were designed to have a melting temperature of 60  5°C.
Gene-speciﬁcprimers(PEPCK:upstreamprimer5GAGTATATCCACATCTGC
GATGGC and reverse primer 5 GGCGAGTCTGTCAGTTCAATACCAATC,
yielding 400-bp product; F-1,6-BPase: upstream primer 5GCTCAACTCGAT
GCTGACTGCC and reverse primer 5 ACCAGGGTTCGACTACCATACAGTG,
yielding 350-bp product; G6Pase: upstream primer 5AGCTGTGGGCATTA
AACTCC and downstream primer 5 AATGCCTGACAGGACTCCAG, yielding
the product of 400 bp) were used for RT-PCR. The RT-PCR product was run
on 1% agarose gel and bands were quantiﬁed using AlphaImager HP (Alpha
Innotech, San Leandro, CA). -Actin was used as an internal control.
Fluorescein isothiocyanate-conjugated insulin binding and internaliza-
tion assay. RLIP76 mouse embryonic ﬁbroblasts (MEFs; 0.1  10
6 cells/ml)
were grown on sterilized glass coverslips (18-mm size) in RPMI-1640 medium
0
50
100
150
200
250
0 30 60 90 120 150
time (min)
b
l
o
o
d
 
s
u
g
a
r
 
(
m
g
/
d
l
)
0
50
100
150
200
250
0 30 60 90 120 150
time (min)
b
l
o
o
d
 
s
u
g
a
r
 
(
m
g
/
d
l
)
0
50
100
150
200
250
0 3 06 09 0 1 2 0 1 5 0
time (min)
b
l
o
o
d
 
s
u
g
a
r
 
(
m
g
/
d
l
)
A B C
FIG. 1. Effect of intraperitoneal administration of insulin on blood glucose in RLIP76
/ vs. RLIP76
/ animals. Level of blood glucose at2h( A)
and 24 h (B) after a single dose of insulin administered intraperitoneally. At readministration of insulin on day 2, the RLIP76
/ blood glucose
level goes down. The insulin sensitivity of RLIP76
/ was magniﬁed signiﬁcantly, with death of all animals before 90 min (C). Blood glucose at
the time of death was undetectable. RLIP76
/, F; RLIP76
/, . Pink and blue indicate no insulin; red and purple indicate insulin dosing.
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PBS. Cells were incubated with 100 ng/ml ﬂuorescein isothiocyanate (FITC)–
conjugated insulin (prepared in PBS containing 1% BSA) for 60 min in ice
(4°C). Cells were then incubated at 37°C in humidiﬁed chamber for 10 min
followed by ﬁxation with 4% paraformaldehyde. Slides were analyzed using
confocal laser scanning microscopy with Zeiss 510 meta system (Carl Zeiss,
Jena, Germany), with excitation at 555 nm and emission at 580 nm.
Preparation and application of insulin-quantum dot. Insulin-quantum dot
(QD) complexes were formed by incubation of insulin (100 nmol/l; Life Tech-
nologies) with QDs 605 ITK (Molecular Probes) at 4°C with mixing for 30 min. A
molar ratio of 6:1 of insulin:QDs was used. To remove unbound ligand, the
complexes were puriﬁed by chromatography over P30 size-exclusion spin columns
(Bio-Rad, Hercules, CA).
Transfection of RLIP76
/ MEFs with RLIP76-pEGFP-C1 vector and
insulin-QD labeling. RLIP76
/ MEFs were transiently transfected with
pEGFP-C1 vector alone or with RLIP76-pEGFP-C1 vector using Lipofectamine
2000 (Invitrogen, Carlsbad, CA). RLIP76
/ control and RLIP76
/-transfected
MEFs (0.1  10
6) were grown on sterilized glass coverslips in RPMI-1640
medium in tissue culture–treated 12-well plates overnight. Cells were labeled with
insulin:QD for 45 min at 4°C, washed with PBS, incubated for 10 min at 37°C, and
ﬁxed in 4% paraformaldehyde. Slides were analyzed by confocal laser scanning
microscopy with Zeiss 510 meta system (excitation 594/emission 610 for insu-
lin:QD and excitation 488/emission 507 nm for GFP-RLIP76).
Fo ¨rster resonance energy transfer analysis. RLIP76
/ MEFs were tran-
siently transfected with pEGFP-C1 vector alone or with RLIP76-pEGFP-C1
vector using Lipofectamine 2000 (Invitrogen). Transfection efﬁciency was
measured by ﬂuorescent microscope (excitation/emission 488/507 nm), and
RLIP76 mRNA expression was evaluated by RT-PCR analysis. RLIP76
/
control and RLIP76
/-transfected MEFs (1  10
5) were grown on sterilized
glass coverslips in RPMI-1640 medium in 12-well plates overnight and were
treated with 10 	mol/l doxorubicin (DOX) or 10 	mol/l glutathione-monochlo-
robimane for 20 min at 37°C, washed with PBS, and ﬁxed in 4% paraformal-
dehyde. Molecular interactions were visualized by Fo ¨rster resonance energy
transfer (FRET) as described (32).
Statistical methods. All data were evaluated with a two-tailed unpaired
Student t test or compared by one-way ANOVA and are expressed as means 
SD. A value of P  0.05 was considered statistically signiﬁcant.
RESULTS
RLIP76 gene interruption causes hypoglycemia and
apparent insulin sensitivity. The baseline blood glucose
in RLIP76
/ mice was 46% lower than in RLIP76
/
animals (P  0.001). At 2 h after insulin injection, blood
glucose dropped by 55% in RLIP76
/ versus 67% in
RLIP76
/ (P  0.01) (Fig. 1A). At 24 h after insulin
injection (Fig. 1B), blood glucose levels had returned to
baseline in all animals. The RLIP76
/ had quantitatively a
very similar response to readministration of insulin on day
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FIG. 2. Glucose tolerance test and lipid levels in RLIP76
/ mice. For the glucose tolerance test, C57B mice (wild-type and RLIP76
/) were fasted
for 6 h followed by oral administration of 2 g/kg body wt glucose using a gavage needle. Each of ﬁve groups consisted of ﬁve animals each. One
group was killed at each time point (0, 5, 30, 60, and 120 min) and 
200–300 l of blood was sampled for glucose analyses. Blood was kept
refrigerated for 
4 h and centrifuged at 3,000g for 10 min, and the serum was separated and stored at 20°C until assay. Glucose, cholesterol,
and triglycerides measurement was performed in the laboratory of Dr. Kent R. Refsal, Michigan State University. *Statistical analyses by ANOVA
were signiﬁcant at P < 0.001 for RLIP76
/ vs. RLIP76
/ animals; n  5.
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RLIP76
/ mice, all of whom died of profound hypoglyce-
mia within 90 min of insulin injection on the second day
(Fig. 1C). These remarkable results indicated that
RLIP76
/ mice are more insulin sensitive, and suggested
that RLIP76 could function to antagonize insulin.
RLIP76 gene interruption improves glucose toler-
ance and plasma lipid levels. Additional evidence for
insulin sensitivity was sought in studies of glucose toler-
ance. Blood glucose levels after oral challenge of 2 g/kg
body wt glucose were consistently and signiﬁcantly lower
in the RLIP76
/ compared with wild type (Fig. 2A)( P 
0.001). In the nonfasting state, blood glucose in RLIP76
/
mice was 46% lower in this study (Fig. 2B), consistent with
the results above (Fig. 1). Fasting blood glucose in the
RLIP76
/ mice decreased by 10%, whereas RLIP76
/
mice had a 35% reduction upon fasting. In addition,
RLIP76
/ mice had lower total serum cholesterol and
triglycerides (43 and 40% of control, respectively; P 
0.01) (Fig. 2C and D). The hypoglycemia is particularly
remarkable because oxidative stress (levels of lipid hy-
droperoxides, lipid alkenals, and alkenal-glutathione con-
jugates) is remarkably increased in the tissues of
RLIP76
/ animals (23,27,33,34). This observation implies
that in the absence of RLIP76, increases in these lipid-
peroxidation products are insufﬁcient by themselves to
turn on any signaling pathway that can increase blood
glucose or lipids.
RLIP76 protein level correlates with insulin-glucose
ratio. The ratio of insulin to blood glucose (a measure of
insulin resistance) was lower in RLIP76
/ or RLIP76
/
mice compared with RLIP76
/ animals (P  0.001) (Fig.
3A). Insulin levels in all females were lower and less
affected by the loss of RLIP76 (Fig. 3B). Insulin sensitivity
appeared to increase with loss of RLIP76. Thus, we
predicted that increasing tissue RLIP76 should increase
insulin resistance. We examined the effect of augmenting
RLIP76 in RLIP76
/ animals using intraperitoneal injec-
tion of puriﬁed recombinant human RLIP76 protein encap-
sulated in liposomes (Fig. 3). Previous studies have
deﬁned the purity, stability, and tissue pharmacology for
RLIP76 delivery by these liposomes (22,27,35,36). Blood
glucose measurements were performed 24 h after intra-
peritoneal injection of liposomes prepared with or without
RLIP76 protein. Western blots of tissue homogenates and
speciﬁc enzyme-linked immunosorbent assays showed sig-
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FIG. 3. Insulin-to-glucose ratio in RLIP76-deﬁcient and -supplemented mice. Twelve-week-old C57BL/6 mice born of heterozygous  heterozygous
mating were genotyped by PCR. Insulin and glucose measurement in blood serum was performed on wild-type (RLIP76
/) animals killed 24 h
after a single intraperitoneal injection of control or RLIP76 liposomes equivalent to 200 and 500 g RLIP76 protein. Insulin and glucose
measurement in blood serum was also performed on heterozygous (RLIP76
/) and homozygous (RLIP76
/) animals. The values are presented
as means  SD from three separate determinations with three replicates (n  9) (A and B). Western blot analyses for RLIP76 were performed
on liver and heart tissues of RLIP76
/ male and female mice killed 24 h after administration of 200 or 500 g RLIP76 protein in the form of
liposomes, intraperitoneally. Aliquots of 100 g detergent-solubilized crude membrane fraction from the liver and heart of animals treated with
200 g (R2) or 500 g (R5) were loaded per lane in SDS-PAGE, transblotted, and probed using anti-RLIP76 IgG primary and peroxidase-
conjugated goat anti-rabbit IgG secondary antibody. The blots were developed with 4-chloro-1-napthol as chromogenic substrate (A and B insets).
-actin expression was used as loading control. Statistical analyses by ANOVA were signiﬁcant at P < 0.01 for RLIP76
/ vs. RLIP76
/, RLIP76
/
vs. RLIP76
/, RLIP76
/ vs. RLIP76
/, and RLIP76
/ vs. RLIP76 proteoliposome–treated RLIP76
/.
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intraperitoneal injection (Fig. 3A and B, insets). The
insulin/glucose ratio was increased in a stepwise fashion
with respect to RLIP76 dose, also more prominently in
males than females. Greater insulin sensitivity of knockout
mice was conﬁrmed by quantitative insulin sensitivity
check index (QUICKI) (37) as well as homeostasis model
assessment (HOMA) (38) analyses for insulin resistance as
well. These ﬁndings indicated that increased tissue RLIP76
increases insulin resistance.
Hyperinsulinemic-euglycemic and hyperglycemic
clamp studies demonstrate peripheral and hepatic
insulin sensitivity of RLIP76
/ mice. Glucose ho-
meostasis was compared in RLIP76
/ versus RLIP76
/
mice using hyperinsulinemic-euglycemic and hyperglyce-
mic clamp. The RLIP76
/ mice were smaller and had
lower fat and muscle mass. Glucose clamp was successful
in maintaining stable blood glucose during the 140-min
study (Fig. 4A). The glucose infusion rate required to
maintain the same glucose level was almost twofold
greater in the RLIP76
/ mice (Fig. 4B). The whole-body
insulin sensitivity index, total peripheral-glucose uptake,
hepatic glycolysis, glycogen synthesis, and hepatic insulin
sensitivity index in the basal state were also greater in
RLIP76
/ mice (Fig. 4C). Under glucose clamp condi-
tions, hepatic glucose output was markedly reduced in
RLIP76
/ animals (Fig. 4D). The remarkable difference
indicates that RLIP76 functions to inhibit the turning off of
gluconeogenesis during the fed state. Because RLIP76 is a
stress-inducible protein, these ﬁndings strongly indicate
that conditions of stress that may increase hepatic RLIP76
levels would tend to antagonize the normal decrease in
hepatic gluconeogenesis in the fed state, potentially exac-
erbating stress hyperglycemia.
Cortisol-induced hyperglycemic response is intact in
RLIP76
/ animals. The above observations led to the
obvious question of how RLIP76 interacts with cortisol,
the most important stress-protective hormone, as well as
the hepatic enzymes that regulate gluconeogenesis,
PEPCK, G6Pase, and F-1,6-BPase. Cortisol-induced hyper-
glycemia was preserved in RLIP76
/ animals, which had
a similar degree of cortisol-induced rise in blood glucose
as RLIP76
/ (Fig. 5).
RLIP76
/ mice have lower activity of PEPCK, F-1,6-
BPase, and G6Pase. Although RLIP76 and cortisol effects
on blood glucose appeared independent, it was clear that
the absolute blood glucose in cortisol-treated RLIP76
/
animals was greater than could be achieved in RLIP76
/
animals. We reasoned that this could be due to effects of
RLIP76 loss on the three principal enzymes that regulate
hepatic gluconeogenesis, PEPCK, F-1,6-BPase, and
G6Pase. To address this possibility, we compared the
mRNA levels and activity of these enzymes between
RLIP76
/ and RLIP76
/ mouse liver tissue. There was
no difference in expression of PEPCK, F-1,6-BPase, or
G6Pase mRNA (Fig. 6A); despite this, the speciﬁc activity
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FIG. 4. Hyperinsulinemic-euglycemic and hyperglycemic clamp studies. Glucose and insulin clamp studies were performed as described in the
RESEARCH DESIGN AND METHODS section at the Mouse Metabolic Phenotyping Center at the Yale University School of Medicine, with procedures
approved by Yale University Institutional Animal Care and Use Committee. Panels A and B demonstrate the result of the hyperinsulinemic-
euglycemic clamp study in which blood glucose of both wild-type (E) and RLIP76
/ () animals was maintained at approximately equal levels
for the 140-min duration of the study (A); the rate of glucose infusion required to maintain equal blood glucose (B) was signiﬁcantly greater for
the RLIP76
/ animals compared with wild-type controls at all experimental time points. Calculated total body glucose turnover, glycolysis, and
hepatic glycogen synthesis (C), and hepatic glucose output in a basal (fasting) as well as hyperglycemic clamp (fed) state (D) are presented.
RLIP76
/ mice, f; RLIP76
/ mice, u. Statistical analyses by ANOVA were signiﬁcant at P < 0.05 for RLIP76
/ vs. RLIP76
/; n  8.
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RLIP76
/ mouse liver. Comparison of these activities in
RLIP76
/ versus RLIP76
/ mouse liver homogenate
treated without or with overnight dialysis showed that
dialyzable inhibitors were present but could not account
for the lower activity of these enzymes in RLIP76
/.
4-HNE, an alkenal shown to increase twofold to threefold
in RLIP76
/ mouse liver (33,34), did not directly affect
the activity of PEPCK or G6Pase but activated F-1,6-BPase
activity. It is remarkable that despite decreased activity of
these key gluconeogenic enzymes, hepatic glucose output
was clearly increased in the knockout animals (Fig. 6B–E).
Baseline and oxidative stress–induced insulin endo-
cytosis is deﬁcient in RLIP76
/ MEFs. Our previous
studies in MEFs derived from RLIP76
/ and RLIP76
/
mice have shown that clathrin-dependent endocytosis of
epidermal growth factor receptor is markedly decreased in
RLIP76
/ MEFs. Because clathrin-dependent endocytosis
has been shown to be a primary mechanism for uptake of
the insulin/insulin-receptor complex (thus terminating, or
antagonizing, insulin signaling), we compared the uptake
of ﬂuorescein-labeled insulin between RLIP76
/ and
RLIP76
/ MEFs. Results of these studies conﬁrmed that
insulin endocytosis is clearly deﬁcient in RLIP76
/ MEFs
(Fig. 7A). Oxidative stress in the form of hydrogen perox-
ide exposure caused a marked increase in endocytosis of
quantum dot–labeled insulin-rhodamine in the RLIP76
/
MEFs, whereas this stress-mediated effect was absent in
RLIP76
/ MEFs (Fig. 7B). Taken together, these results
offer strong support for a model in which RLIP76 functions
to antagonize insulin signaling, and that stress conditions
known to induce RLIP76 would tend to exacerbate insulin
resistance (20,26,39).
Analysis of interactions among RLIP76, its trans-
ported substrates, and insulin by FRET. To directly
determine whether RLIP76 migrated with insulin in the
endocytic vesicle, we expressed GFP-RLIP76 into
RLIP76
/ MEFs and examined the endocytosis of
rhodamine-labeled insulin using confocal laser micros-
copy and FRET analysis (Fig. 7C). These studies also
demonstrated that the internalization of rhodamine-
labeled insulin was also deﬁcient in RLIP76
/ MEFs.
Whereas empty green ﬂuorescent protein (GFP) vector
protein did not affect the internalization of rhodamine-
insulin, transfection of RLIP76-GFP restored the internal-
ization of insulin.
Because insulin is present on the outside of the cell
membrane and RLIP76 is associated with the endocytosis
machinery on the inner membrane leaﬂet, we predicted
that although the red and green ﬂuorescence is internal-
ized together, there should be no direct FRET interaction
between the red and green because the distance between
the two ﬂuorescent ligands should exceed 100 nm. Results
of FRET analysis were consistent with this prediction
(Fig. 7D).
FRET analysis can demonstrate speciﬁc binding of
transported substrates to RLIP76. The validity of the
FRET analysis was conﬁrmed using the ﬂuorescent anthra-
cycline drug, DOX, which is known to bind to RLIP76 as
well as GSH-monochlorobimane. Results of FRET studies
are presented in Fig. 8. The top images show the observed
intensities for respective samples, and below the histo-
gram graph presents observed ﬂuorescence lifetime mea-
sured for the respective images (Fig. 8A and B). For
monochlorobimane (MCB) alone (histogram in red), the
signal is very bright and the ﬂuorescence lifetime is long,
as expected, 
9 ns with relatively narrow distribution
(Fig. 8B). Addition of RLIP76-GFP results in dramatic
shortening of MCB ﬂuorescence lifetime, which drops to

4 ns (histogram in red). The lifetime distribution is now
relatively broad. This could reﬂect small heterogeneity of
distances and/or relative orientations between MCB chro-
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/ animals; n  5.
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lifetime indicates strong interaction (very close proximity
of two molecules), which is entirely consistent with our
hypothesis. The right lower panel (Fig. 8C) shows the
lifetime histogram for GFP only (green) and ﬂuorescence
of GFP in the presence of DOX (blue). The ﬂuorescence
lifetime of GFP in the presence of DOX is shorter, con-
ﬁrming that DOX clearly did interact with the green
ﬂuorescence protein of RLIP76. The interaction of GSH-
monochlorobimane ﬂuorescent conjugate was much more
clearly evident and indicated speciﬁc binding of the con-
jugate (Fig. 8B).
Effect of RLIP76 loss or augmentation on basal and
insulin-stimulated change in glucose uptake and RTK
signaling. RLIP76
/ and RLIP76
/ MEFs were trans-
fected with pcDNA3.1 empty vector (V) or pcDNA3.1 with
full-length RLIP76 cDNA (R) using Lipofectamine (Invitro-
gen). Western blot analyses of the 28,000g crude superna-
tant of homogenate of these cells against anti-RLIP76 IgG
demonstrated the absence of RLIP76 antigen in RLIP76
/
MEFs, and showed increased RLIP76 protein upon trans-
fection in both RLIP76
/ an RLIP76
/ MEFs (Fig. 9A). A
factorial experiment (2 [genotype]  2 [RLIP76 overex-
pression]  2 [anti-RLIP76 antibody]  2 [insulin]) was
designed to measure and compare the effect of insulin on
glucose uptake, Foxo-1 inactivation, and activation of Akt,
Jun NH2-terminal kinase (JNK, and Hsf-1. The results,
normalized to the control group, RLIP76
/ MEFs trans-
fected with empty vector, treated with no insulin and
preimmune IgG are presented (Fig. 9B–D). In control
RLIP76
/ MEFs, treatment with anti-RLIP76 IgG, previ-
ously shown to inhibit the transport activity of RLIP76 by
binding to a cell surface epitope, caused a signiﬁcant
increase in activation of Hsf-1, JNK, and Akt, a slight
suppression of Foxo, and a 40% increase in uptake of
glucose, in the absence of insulin. This ﬁnding indicated
that inhibition of RLIP76 in normal cells activates stress
pathways, and increases uptake of glucose through an
insulin-independent mechanism. Insulin caused the ex-
pected effects of a more than twofold increase in glucose
uptake, accompanied by activation of Hsf-1, Akt, and JNK,
and inactivation of Foxo. In the presence of both insulin
and anti-RLIP76 IgG, glucose uptake as well as signaling
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net effect was consistent with an additive effect.
RLIP76 overexpression in the RLIP76
/ MEFs caused
an effect opposite to that of the antibody, a suppression of
Hsf-1, JNK, and Akt, and activation of Foxo, as well as a
reduction of glucose uptake to half that seen with empty
vector transfection. Treatment of RLIP76-overexpressing
RLIP76
/ MEFs with antibody restored Hsf-1, Akt, and
JNK as well as glucose uptake to slightly greater than
control. Treatment with insulin resulted in expected in-
crease in Hsf-1, Akt, and JNK and decrease in Foxo, but
the magnitude of this response was suppressed signiﬁ-
cantly. Most strikingly, the glucose uptake in response to
insulin, although 
1.8-fold compared with the absence of
insulin, was still less than the control, and only one-third
of that seen in empty vector–transfected cells. As in the
vector-transfected cells, anti-RLIP76 IgG pretreatment re-
sulted in augmentation of insulin response with respect to
Hsf-1, JNK, and Akt, but suppression of Foxo was less
prominent compared with control. These observations
argue strongly for the assertion that RLIP76 functions to
antagonize insulin signaling broadly and directly, and that
conditions in which RLIP76 is elevated result in decreased
response to insulin (resistance). Furthermore, RLIP76 also
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FIG. 7. Effect of RLIP76 on insulin internalization. Insulin binding and internalization were studied in RLIP76 MEF
/ and RLIP76 MEF
/ using
FITC-insulin. Cells (0.1  10
6 cells/ml) grown on the sterilized coverslips were incubated with FITC-insulin (100 ng/ml) for 45 min in ice followed
by incubation for 10 min at 37°C. Cells were ﬁxed and analyzed by confocal laser microscopy. Photographs taken at identical exposure at 400
magniﬁcation are presented (A). Stress-mediated effect on insulin internalization. RLIP76
/ and RLIP76
/ MEFs (0.1  10
6 cells/ml) were
grown on coverslips, followed by incubation with 50 mol/l H2O2 for 20 min at 37°C, and were allowed to recover for 2 h. Cells were treated with
molar ratio 6:1 of insulin-rhodamine:QD on ice for 45 min, washed, incubated for 10 min at 37°C, and ﬁxed in cold 4% paraformaldehyde. Slides
were analyzed using confocal laser-scanning microscopy. Photographs taken at identical exposure at 400 magniﬁcation are presented (B).
Effect of RLIP76 on insulin internalization using insulin-QD complexes. Insulin binding and internalization were studied in MEF
/, MEF
/, and
MEF
/ transfected with empty GFP vector and RLIP76-GFP vector, using insulin-QD complexes. Insulin-QD complexes were formed by
incubation of insulin (40 nmol/l; Life Technologies) with QDs 605 ITK amino (PEG; Molecular Probes) at 4°C for 30 min. A molar ratio of 6:1 of
insulin:QDs was used. Cells grown on the sterilized coverslips were treated with insulin-QD complexes for 10 min at 37°C. Cells were ﬁxed and
analyzed using confocal laser scanning microscopy with Zeiss 510 meta system, with excitation at 594 nm and emission at 610 nm. Photographs
taken at identical exposure at 400 magniﬁcation are presented (C). The molecular interactions between the RLIP76 and insulin were checked
by FRET analysis as described in the RESEARCH DESIGN AND METHODS section. The FRET analysis clearly indicated that there is no direct interaction
of RLIP76 and insulin (D). (A high-quality digital representation of this ﬁgure is available in the online issue.)
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take as might be expected if glucose transporters were
also subjected to increased rate of endocytosis.
Consistent with this model, the comparison of
RLIP76
/ MEFs with RLIP76
/ MEFs showed a higher
baseline activation of Hsf-1, JNK, and Akt, and lower Foxo.
Glucose uptake in the absence of insulin in the RLIP76
/
MEFs was 60% higher as well, indicating that the lack of
RLIP76 results in a state in which basal (insulin-independent)
uptake of glucose is increased. This is likely to be the
major underlying explanation for fasting hypoglycemia
and increased glucose utilization in RLIP76
/ mice. As
expected, anti-RLIP76 IgG treatment of RLIP76
/ MEFs
did not cause a signiﬁcant change in the parameters
measured. Insulin responsiveness with respect to changes
in Hsf-1, JNK, Akt, and Foxo was preserved in RLIP76
/
cells, although the fold change in glucose uptake was
actually slightly lower. This was due to a higher baseline
insulin-independent signaling effects and glucose uptake,
and a likely ceiling effect of maximal possible glucose
uptake, possibly determined by the number of glucose
transporters present for translocation to the membrane.
The anti-RLIP76 IgG had no effect on these parameters in
RLIP76
/ MEFs, indicating that observed effects of this
antibody in RLIP76
/ MEFs are due to a speciﬁc interac-
tion of these antibodies with RLIP76 rather than any
nonspeciﬁc effect.
Transfection of RLIP76 into RLIP76
/ MEFs resulted in
restoration of the pattern of signaling and glucose uptake
rate to that found in control RLIP76
/ MEFs; after
transfection with RLIP76, response to anti-RLIP76 IgG (in
terms of increased glucose uptake and increased signal-
ing) was restored. Although the magnitude of insulin
response was blunted somewhat compared with the un-
transfected RLIP76
/ MEFs, transfection with RLIP76
caused a heightened response when cells were treated
with both insulin and anti-RLIP76 IgG.
Taken together, these ﬁndings are consistent with a
model in which RLIP76 functions to antagonize peripheral
cellular glucose uptake through both insulin-dependent as
well as insulin-independent mechanisms, and conditions
that increased RLIP76 should result in reduced uptake of
glucose in peripheral cells.
DISCUSSION
Our studies show that RLIP76 regulates blood glucose by
controlling insulin-dependent and insulin-independent
mechanisms of cellular glucose uptake in both peripheral
and hepatic tissues. The striking lack of endocytosis in
RLIP76
/ MEFs appears to be the major overall pertur-
bation responsible for the observed global effects on
glucose homeostasis and signaling. The central role of
RLIP76 in glycemic regulation is also evident from para-
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the observed intensities for respective samples (A). Below the histogram, the graph presents observed ﬂuorescence lifetime measured for the
respective images. For MCB alone (histogram in red), the signal is very bright and ﬂuorescence lifetime is long, as expected, 
9 ns with the
relatively narrow distribution. Addition of RLIP76-GFP results in dramatic shortening of MCB ﬂuorescence lifetime, which dropped to 
4n s
(histogram in red) (B). The validity of the FRET analysis was conﬁrmed using the ﬂuorescent anthracycline drug, DOX, which is known to bind
to RLIP76. C: Lifetime histogram for GFP only (green) and ﬂuorescence of GFP in the presence of DOX (blue). The ﬂuorescence lifetime of GFP
in the presence of DOX is shorter, conﬁrming that DOX clearly did interact with the green ﬂuorescence protein of RLIP76. (A high-quality digital
representation of this ﬁgure is available in the online issue.)
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presence of several fold increased levels of oxidative
stress–derived free radicals, lipid peroxidation products, and
activated JNK, and p38 (23–27,33,39). If small-molecule
products of oxidative degradation could themselves in-
crease insulin resistance, we should expect that
RLIP76
/ mice should be quite insulin resistant because
they have several fold higher levels of tissue hydroperox-
ides compared with RLIP76
/ mice (23,33,34); this was
obviously not the case.
To explain this apparent paradox, our model proposes
that lipid peroxidation products mediate insulin resistance
because their GS-E conjugates are necessary substrates
for RLIP76 to drive the process of endocytosis—in the
absence of RLIP76 and of endocytosis, the “dwell time” of
insulin at the plasma membrane is greater, resulting in
greater insulin sensitivity. Increasing RLIP76 in cells inhib-
its insulin-independent glucose uptake, and antagonizes
insulin-independent glucose uptake. Because clathrin-de-
pendent endocytosis exerts broad effects on receptor-
ligand signaling (including G-protein–linked receptors) as
well as on trafﬁcking of membrane proteins (such as
GLUT), the insulin-independent effects are understand-
able, and in some ways expected. Because lipid trafﬁcking
between peripheral and hepatic tissues is also intricately
linked with clathrin-dependent endocytosis (23–25,39), it
is also perhaps not surprising that both blood cholesterol
and triglycerides were lower in RLIP76
/ animals. These
ﬁndings are of clinical interest because both hyperglyce-
mia and hyperlipidemia could be treated by targeting
RLIP76. Because RLIP76 is a known stress-inducible pro-
tein, conditions that increase RLIP76 expression (i.e.,
oxidative stress) will cause insulin resistance and hyper-
lipidemia. More importantly, in the absence of RLIP76,
0
1
2
3
4
5
10
10
1
1
0.1
0.1
0.01
P
I
S
R
L
I
P
7
6
P
I
S
R
L
I
P
7
6
P
I
S
R
L
I
P
7
6
P
I
S
R
L
I
P
7
6
P
I
S
R
L
I
P
7
6
P
I
S
R
L
I
P
7
6
P
I
S
R
L
I
P
7
6
P
I
S
R
L
I
P
7
6
0 mU 20 mU 0 mU 20 mU 0 mU 20 mU 0 mU 20 mU
Empty-vector RLIP76 Empty-vector RLIP76
+/+ -/-
f
o
l
d
 
c
h
a
n
g
e
 
o
v
e
r
 
c
o
n
t
r
o
l
Hsf-1 JNK AKT FOXO Glucose uptake
Antibody
Insulin
Transfection
Genotype
A
R
L
I
P
7
6
W
e
s
t
e
r
n
 
b
l
o
t
Internal control
206 K
107 K
79 K
48 K
35 K
29 K
21 K
8 K
std
MEF+/+ MEF-/-
V V+R
1      2      3      4 
V V+R
Glucose Uptake
f
o
l
d
 
c
h
a
n
g
e
 
o
v
e
r
 
c
o
n
t
r
o
l
Hsf-1
JNK
AKT
FOXO
 
 
79 K
48 K
 
                                                           
 
 
 
                                                           
79 K
48 K
                                                                                                                                   
(β-actin)
(β-actin)
(β-actin)
p
A
K
T
H
s
f
1
 
 
 
                                                           
 
                                                           
                                                                                                                                   
B
C
Genotype +/+ +/+ +/+ +/+ +/+ +/+ +/+ +/+ -/- -/- -/- -/- -/- -/- -/- -/-
T r a n s f e c t i o n VVVVRRRRVVVVRRRR
I n s u l i n 0 02 0 2 00 02 02 00 02 0 2 00 02 0 2 0
Antibody
S
T
D
CA RCA RCA RC A RCA RCA RCA RCA R
D
FIG. 9. Regulation of signaling via Hsf-1, Akt, JNK, and FOXO-1 by RLIP76. RLIP76
/ and RLIP76
/ MEFs were subjected to transfection with
pcDNA3.1 empty vector (V) or pcDNA3.1 with full-length RLIP76 cDNA (R) using Lipofectamine (Invitrogen). Crude supernatant of 28,000g of
these cells was subjected to Western blot analysis against anti-RLIP76 IgG to demonstrate the absence of RLIP76 antigen in RLIP76
/ MEFs and
to show increased RLIP76 protein upon transfection in both RLIP76
/ and RLIP76
/ MEFs. -Actin was used as an internal control (A). The
effect of RLIP76 overexpression, insulin, or anti-RLIP76 antibody on RLIP76
/ and RLIP76
/ MEFs on signaling as well as glucose uptake was
carried out at 37°C with 5% CO2 atmosphere. The cells were pretreated with either polyclonal rabbit preimmune IgG (C or PIS) or anti-human
RLIP76 IgG fractions (AR) (40 g/ml ﬁnal concentration) for 1 h. Buffer containing
14C-glucose and either no insulin or 20 mU insulin was added
to start the measurement of glucose uptake, and the measurement was terminated at 30 min by washing off the medium with ice-cold PBS and
solubilization of cells in counting cocktail. Glucose uptake was measured in 5  10
6 cells, as described previously (36). In parallel experiments
in which
14C glucose was omitted, measurements of phosphorylation of Akt, Hsf-1, and JNK, and inactivation of Foxo1, were performed at 30 min.
Results of Western blot analyses of Hsf-1 expression and phospho-Akt (Ser473; Millipore, Billerica, MA) are presented. -actin expression was
shown to conﬁrm equal amount of protein was loaded in each sample (B). Results from all groups were analyzed with plots of glucose uptake vs.
Hsf-1 expression and Akt activation as well as Foxo-1 inactivation and JNK phosphorylation (measured by ELISA; Active Motif, Carlsbad, CA)
(C). Results of all ﬁve measurements normalized to the control group (RLIP76
/ MEFs transfected with empty vector, treated with no insulin
and preimmune IgG) are presented (D). Means  SD for two separate experiments, each in triplicate, are shown; n  6 (33,36).
S. AWASTHI AND ASSOCIATES
diabetes.diabetesjournals.org DIABETES, VOL. 59, MARCH 2010 723oxidative stress alone is insufﬁcient to mediate insulin
resistance (23,26).
The central stress-response role of RLIP76 is also evi-
dent from the effects of RLIP76 loss on stress-responsive
kinase signaling, which are activated but insufﬁcient to
mediate insulin resistance. Elevated heat shock proteins
are expected because RLIP76 is known to bind to and
sequester Hsf-1, the master transcriptional regulator of the
heat shock response. Thus, RLIP76 functions as the pri-
mary regulator (inhibitor) of transcription of chaperones,
which are dramatically increased in tissue of RLIP76
/
mice (33,36,39). Decreased levels of chaperone heat shock
proteins have been correlated with insulin resistance (40);
thus elevated chaperone levels could also contribute to the
observed insulin sensitivity of RLIP76
/ mice. MEF stud-
ies show that Hsf-1, JNK, and Akt are activated, and their
activation is directly correlated with glucose uptake in
response to insulin; FOXO is inactivated by insulin, and its
activity is inversely correlated with insulin-dependent glu-
cose uptake. All signaling responses are blunted by RLIP76
overexpression, again emphasizing the overarching role of
clathrin-dependent endocytosis in signaling regulation,
and the crucial rate-regulatory role of RLIP76 in clathrin-
dependent endocytosis.
Increased insulin sensitivity in short-term (clamp stud-
ies) in both peripheral and hepatic tissues of C57B mice,
and the dramatic effects of repeat insulin administration in
RLIP76
/ animals, are entirely consistent with our model.
In the absence of RLIP76, in the fed state, hepatic glucose
output is nearly abrogated in RLIP76
/ mice, whereas it
is only slightly suppressed in RLIP76
/; these ﬁndings
imply that inhibition of RLIP76 could have a salutary effect
by reducing hepatic glucose output. The complex interac-
tions of insulin-dependent and insulin-independent regula-
tors of glycemic control in the whole animal are likely to
yield interesting and perhaps paradoxical observations,
with further experimental manipulations planned to eval-
uate the effects of RLIP76 loss on interactions among diet,
insulin, glucagon, and glucocorticoids.
Glucocorticoid-mediated hyperglycemia is known to be
mediated both through increased gluconeogenesis (41)
and through increased insulin resistance (42). Diminished
hyperglycemic effect of hydrocortisone in RLIP76
/ mice
indicates a regulatory role of RLIP76 in glucocorticoid
action. It should be noted that glucocorticoid receptor
knockout mice are hypoglycemic only when stressed;
RLIP76
/ mice are hypoglycemic at baseline—despite
the fact that they have relatively higher hepatic glucose
output than the RLIP76
/ mice. These observations imply
a fundamental increase in both hepatic and peripheral
insulin sensitivity in RLIP76
/ mice.
Present studies have important implications in the un-
derstanding of mechanisms governing the phenomenon of
insulin resistance associated with clinical disease condi-
tions in which oxidative stress is increased. They predict
that an invariable consequence of oxidative stress is an
increase in formation of GS-E conjugates in cells, resulting
in an increased rate of their efﬂux, and a consequent
increase in the rate of internalization of membrane recep-
tor/ligand complexes; by the same token, conditions or
agents that reduce oxidative stress and GS-E conjugate
formation should result in an increased dwell time of
receptor/ligand couples in plasma membrane, increasing
signaling efﬁciency. Another important corollary to
present ﬁndings is that small molecules that interact with
RLIP76, either at the cell surface or internally at one or
more sites known to regulate its transport activity, could
potentially function as novel hypoglycemic and hypolipi-
demic agents.
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